Results 11 to 20 of about 187,468 (310)
The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study [PDF]
Background: Statins have emerged as a vital therapeutic option for dyslipidemia, effectively reducing morbidity and mortality in individuals with various medical conditions.
Hany A. Al-hussaniy +3 more
doaj +3 more sources
A multistate transition model for statin‐induced myopathy and statin discontinuation
The overarching goal of this study was to simultaneously model the dynamic relationships among statin exposure, statin discontinuation, and potentially statin‐related myopathic outcomes.
Yuxi Zhu +9 more
doaj +1 more source
Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
A growing number of patients with metabolic disorders are receiving statin and antidiabetic therapies as comedications. A signal of increased risk of myotoxicity due to potential interactions between antidiabetics and statins has been detected in ...
Keunhyeong Bak +4 more
doaj +1 more source
Statin use and cognitive function: population-based observational study with long-term follow-up. [PDF]
We aimed to evaluate the association between statin use and cognitive function. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0; best score, 175 points) and the Visual Association Test (VAT; low performance, 0-10;
Hanneke Joosten +6 more
doaj +1 more source
Background: Statin intolerance impacts approximately 10% of statin users, with side effects ranging from mild myalgia to extreme intolerance resulting in myopathy and rhabdomyolysis.
Alaa’ Lutfi Melhem +11 more
doaj +1 more source
Statins are among the most commonly prescribed medications worldwide. Statin-associated muscle symptoms (SAMS) represent a frequent statin-related adverse effect associated with statin discontinuation and increased cardiovascular disease (CVD) events ...
Blanca Gavilán-Carrera +4 more
doaj +1 more source
Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus [PDF]
Purpose: This paper reports the results of an audit that assessed the prevalence of residual hypertriglyceridemia and the potential need for intensified management among patients with statin-treated type 2 diabetes mellitus (T2DM) in primary care in the ...
Greener, Mark +2 more
core +2 more sources
Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
Background PCSK9is (proprotein convertase subtilisin/kexin type 9 inhibitors) are well tolerated, potently lower cholesterol, and decrease cardiovascular events when added to statins.
Christopher LaFratte +5 more
doaj +1 more source
Statins (inhibitors of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) are a group of drugs used to treat lipid disorders. They inhibit cholesterol synthesis at an early stage of the biosynthesis pathway, thus eliminating numerous metabolites involved in the cycle.
Stryjkowska-Góra, Aleksandra +3 more
openaire +2 more sources
Phenotype standardization for statin-induced myotoxicity. [PDF]
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis.
Fahy, J. +41 more
core +1 more source

